米国の乳房MRI市場規模、シェア、動向分析：製品別、撮像技術/造影用途別、状態別、最終用途別、セグメント別予測、2025年～2033年

米国の乳房MRI市場サマリー

米国の乳房MRI市場規模は、2024年に7億9,361万米ドルと推計され、2033年には18億7,880万米ドルに達すると予測され、2025年から2033年までのCAGRは10.05%で成長すると予測されます。米国における乳房用MRIの需要は、乳がんの有病率の上昇と医療用画像処理に対する需要の高まりに加え、臨床試験の増加や磁気共鳴画像の継続的な技術進歩により増加しています。

乳がんやその他の乳房関連異常の有病率の増加は、市場の拡大を大きく促進すると予想されます。National Breast Cancer Foundation, Inc.が2025年6月に発表したデータによると、米国では女性の約8人に1人が生涯のうちに乳がんと診断されるといいます。また、国際がん研究機関の予測では、2022年から2050年の間に米国における乳がん罹患率が27.8％増加し、2050年には罹患者数が約350,693人に達すると予想されています。このようながん罹患率の大幅な増加は、国全体の乳房磁気共鳴画像法に対する需要を煽ると予想されます。

さらに、がん検出のための先進的な磁気共鳴画像法を評価し、革新的な画像ソリューションを開発する臨床試験の増加が、市場成長に大きく貢献すると予想されます。これらの臨床試験は、診断精度の向上、早期発見の強化、新技術の検証において極めて重要です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の乳房MRI市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 米国の乳房MRI市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の乳房MRI市場：製品推定・動向分析

• セグメントダッシュボード
• 米国の乳房MRI市場における製品変動分析
• 米国の乳房MRI市場規模と動向分析（製品別、2021～2033年）
• システム
• コイル
• ソフトウェア

第5章 米国の乳房MRI市場：画像技術／造影用途推定・動向分析

• セグメントダッシュボード
• 米国の乳房MRI市場における画像技術/造影用途変動分析
• 米国の乳房MRI市場規模と動向分析（画像技術別/造影用途別、2021～2033年）
• 造影MRI（CE-MRI）
• 非造影/短縮乳房MRI（Ab-MRI）

第6章 米国の乳房MRI市場：状態推定・動向分析

• セグメントダッシュボード
• 米国の乳房MRI市場の状況変動分析
• 米国の乳房MRI市場規模と動向分析（状態別、2021～2033年）
• 良性
• 悪性

第7章 米国の乳房MRI装置：最終用途推定・動向分析

• セグメントダッシュボード
• 米国の乳房MRI市場の最終用途変動分析
• 米国の乳房MRI市場規模と動向分析（最終用途別、2021～2033年）
• 病院と診療所
• 診断画像センター
• 乳がんケアセンター
• 学術調査機関
• その他

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
  • Innovators
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • Key customers
  • US key company market share analysis, 2024
  • GE HealthCare
  • Siemens Medical Solutions USA, Inc.
  • Koninklijke Philips NV
  • Canon Medical Systems
  • Fujifilm Healthcare
  • United Imaging Healthcare Co., Ltd.
  • AURORA HEALTHCARE US CORP
  • QED（Quality Electrodynamics）
  • MR Instruments, Inc.
  • iCAD Inc.
  • Subtle Medical, Inc.
  • Arterys（Tempus）
• ヒートマップ分析/企業市況分析
• 2024年の企業市場シェア予測分析
• その他の主要市場企業のリスト

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. breast MRI market, by product, 2021 - 2033 (USD Million)
• Table 4 U.S. breast MRI market, by imaging technique/contrast use, 2021 - 2033 (USD Million)
• Table 5 U.S. breast MRI market, by end use, 2021 - 2033 (USD Million)
• Table 6 U.S. breast MRI market, by condition, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Breast MRI Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 U.S. Breast MRI Market, for Product, 2021 - 2033 (USD Million)
• Fig. 14 U.S. Breast MRI Market, for Systems, 2021 - 2033 (USD Million)
• Fig. 15 U.S. Breast MRI Market, for Closed MRI Systems, 2021 - 2033 (USD Million)
• Fig. 16 U.S. Breast MRI Market, for Open MRI Systems, 2021 - 2033 (USD Million)
• Fig. 17 U.S. Breast MRI Market, for 1.5 Tesla (1.5T), 2021 - 2033 (USD Million)
• Fig. 18 U.S. Breast MRI Market, for 3 Tesla (3T), 2021 - 2033 (USD Million)
• Fig. 19 U.S. Breast MRI Market, for 7 Tesla (7T), 2021 - 2033 (USD Million)
• Fig. 20 U.S. Breast MRI Market, for 3D Breast MRI, 2021 - 2033 (USD Million)
• Fig. 21 U.S. Breast MRI Market, for 4D Breast MRI, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Breast MRI Market, for Coils, 2021 - 2033 (USD Million)
• Fig. 23 U.S. Breast MRI Market, for Unilateral Breast Coils, 2021 - 2033 (USD Million)
• Fig. 24 U.S. Breast MRI Market, for Bilateral Breast Coils, 2021 - 2033 (USD Million)
• Fig. 25 U.S. Breast MRI Market, for 8-Channel Breast Coils, 2021 - 2033 (USD Million)
• Fig. 26 U.S. Breast MRI Market, for 16-Channel Breast Coils, 2021 - 2033 (USD Million)
• Fig. 27 U.S. Breast MRI Market, for Diagnostic-Only Coils, 2021 - 2033 (USD Million)
• Fig. 28 U.S. Breast MRI Market, for Biopsy-Compatible Breast Coils, 2021 - 2033 (USD Million)
• Fig. 29 U.S. Breast MRI Market, for Software, 2021 - 2033 (USD Million)
• Fig. 30 U.S. Breast MRI Market, for Imaging Technique/Contrast Use, 2021 - 2033 (USD Million)
• Fig. 31 U.S. Breast MRI Market, for Contrast-Enhanced MRI (CE-MRI), 2021 - 2033 (USD Million)
• Fig. 32 U.S. Breast MRI Market, for Non-Contrast/Abbreviated Breast MRI (Ab-MRI), 2021 - 2033 (USD Million)
• Fig. 33 U.S. Breast MRI Market, for Conditions, 2021 - 2033 (USD Million)
• Fig. 34 U.S. Breast MRI Market, for Benign, 2021 - 2033 (USD Million)
• Fig. 35 U.S. Breast MRI Market, for Malignant, 2021 - 2033 (USD Million)
• Fig. 36 U.S. Breast MRI Market, for End Use, 2021 - 2033 (USD Million)
• Fig. 37 U.S. Breast MRI Market, for Hospitals and Clinics, 2021 - 2033 (USD Million)
• Fig. 38 U.S. Breast MRI Market, for Diagnostic Imaging Centers, 2021 - 2033 (USD Million)
• Fig. 39 U.S. Breast MRI Market, for Breast Care Centers, 2021 - 2033 (USD Million)
• Fig. 40 U.S. Breast MRI Market, for Academic & Research Institutes, 2021 - 2033 (USD Million)
• Fig. 41 U.S. Breast MRI Market, for Others, 2021 - 2033 (USD Million)

U.S. Breast MRI Market Summary

The U.S. breast MRI market size was estimated at USD 793.61 million in 2024 and is projected to reach USD 1,878.8 million by 2033, growing at a CAGR of 10.05% from 2025 to 2033. The demand for breast MRI in the U.S. is increasing due to the rising prevalence of breast cancer and the growing demand for medical imaging, along with growing clinical trials and continuous technological advancements in magnetic resonance imaging.

The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive market expansion significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. will be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.

Furthermore, the increasing number of clinical trials evaluating advanced magnetic resonance imaging modalities for cancer detection and developing innovative imaging solutions is expected to contribute significantly to market growth. These trials are crucial in improving diagnostic accuracy, enhancing early detection, and validating new technologies.

U.S. Breast MRI Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast MRI market report based on product, imaging technique/contrast use, condition, and end-use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Systems
  • By MRI System Type
  • Closed MRI Systems
  • Open MRI Systems
  • By Field Strength
  • 1.5 Tesla (1.5T)
  • 3 Tesla (3T)
  • 7 Tesla (7T)
  • By Dimensional Modality
  • 3D Breast MRI
  • 4D Breast MRI
• Coils
  • By Coil Configuration
  • Unilateral Breast Coils
  • Bilateral Breast Coils
  • By Channel Count
  • 8-Channel Breast Coils
  • 16-Channel (or Higher) Breast Coils
  • By Functionality
  • Diagnostic-Only Coils
  • Biopsy-Compatible Breast Coils
• Software
• Imaging Technique / Contrast Use Outlook (Revenue, USD Million, 2021 - 2033)
• Contrast-Enhanced MRI (CE-MRI)
• Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
• Condition Outlook (Revenue, USD Million, 2021 - 2033)
• Malignant
• Benign
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Diagnostic Imaging Centers
• Breast Care Centers
• Academic & Research Institutes
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Imaging Technique/Contrast Use
  • 1.1.3. Condition
  • 1.1.4. End use
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Breast MRI Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing burden of breast cancer
    • 3.2.1.2. Rising awareness about early diagnosis
    • 3.2.1.3. Favorable government initiatives
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Alternative approaches for breast cancer management
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Rising number of clinical trials
    • 3.2.3.2. Increasing funding and investments
    • 3.2.3.3. Advancements in technology
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Shortage of radiologists
• 3.3. U.S. Breast MRI Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Breast MRI Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Breast MRI Market Product Movement Analysis
• 4.3. U.S. Breast MRI Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Systems
  • 4.4.1. Systems market estimates and forecasts for 2021 - 2033 (USD Million)
    • 4.4.1.1. By MRI System Type
      • 4.4.1.1.1. Closed MRI Systems
        • 4.4.1.1.1.1. Closed MRI systems market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.4.1.1.2. Open MRI Systems
        • 4.4.1.1.2.1. Open MRI systems market estimates and forecasts for 2021 - 2033 (USD Million)
    • 4.4.1.2. By Field Strength
      • 4.4.1.2.1. 1.5 Tesla (1.5T)
        • 4.4.1.2.1.1. 1.5 Tesla (1.5T) market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.4.1.2.2. 3 Tesla (3T)
        • 4.4.1.2.2.1. 3 Tesla (3T) market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.4.1.2.3. 7 Tesla (7T)
        • 4.4.1.2.3.1. 7 Tesla (7T) market estimates and forecasts for 2021 - 2033 (USD Million)
    • 4.4.1.3. By Dimensional Modality
      • 4.4.1.3.1. 3D Breast MRI
        • 4.4.1.3.1.1. 3D breast MRI market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.4.1.3.2. 4D Breast MRI
        • 4.4.1.3.2.1. 4D breast MRI market estimates and forecasts for 2021 - 2033 (USD Million)
• 4.5. Coils
  • 4.5.1. Coils market estimates and forecasts for 2021 - 2033 (USD Million)
    • 4.5.1.1. By Coil Configuration
      • 4.5.1.1.1. Unilateral Breast Coils
        • 4.5.1.1.1.1. Unilateral breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.5.1.1.2. Bilateral Breast Coils
        • 4.5.1.1.2.1. Bilateral breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
    • 4.5.1.2. By Channel Count
      • 4.5.1.2.1. 8-Channel Breast Coils
        • 4.5.1.2.1.1. 8-channel breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.5.1.2.2. 16-Channel Breast Coils
        • 4.5.1.2.2.1. 16-channel breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
    • 4.5.1.3. By Functionality
      • 4.5.1.3.1. Diagnostic-Only Coils
        • 4.5.1.3.1.1. Diagnostic-only coils market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.5.1.3.2. Biopsy-Compatible Breast Coils
        • 4.5.1.3.2.1. Biopsy-compatible breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
• 4.6. Software
  • 4.6.1. Software market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast MRI Market: Imaging Technique / Contrast Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Breast MRI Market Imaging Technique / Contrast Use Movement Analysis
• 5.3. U.S. Breast MRI Market Size & Trend Analysis, by Imaging Technique / Contrast Use, 2021 to 2033 (USD Million)
• 5.4. Contrast-Enhanced MRI (CE-MRI)
  • 5.4.1. Contrast-Enhanced MRI (CE-MRI) market estimates and forecasts for 2021 - 2033 (USD Million)
• 5.5. Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
  • 5.5.1. Non-Contrast / Abbreviated Breast MRI (Ab-MRI) market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast MRI Market: Condition Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Breast MRI Market Condition Movement Analysis
• 6.3. U.S. Breast MRI Market Size & Trend Analysis, by Condition, 2021 to 2033 (USD Million)
• 6.4. Benign
  • 6.4.1. Benign market estimates and forecasts for 2021 - 2033 (USD Million)
• 6.5. Malignant
  • 6.5.1. Malignant market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 7. U.S. Breast MRI Devices: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Breast MRI Market End Use Movement Analysis
• 7.3. U.S. Breast MRI Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals and Clinics
  • 7.4.1. Hospitals and clinics market estimates and forecasts for 2021 - 2033 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 - 2033 (USD Million)
• 7.6. Breast Care Centers
  • 7.6.1. Breast care centers market estimates and forecasts for 2021 - 2033 (USD Million)
• 7.7. Academic & Research Institutes
  • 7.7.1. Academic & research institutes market estimates and forecasts for 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Others market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. U.S. key company market share analysis, 2024
  • 8.3.4. GE HealthCare
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Siemens Medical Solutions USA, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Koninklijke Philips N.V.
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Canon Medical Systems
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Fujifilm Healthcare
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. United Imaging Healthcare Co., Ltd.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. AURORA HEALTHCARE US CORP
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. QED (Quality Electrodynamics)
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. MR Instruments, Inc.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. iCAD Inc.
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Subtle Medical, Inc.
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Arterys (Tempus)
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
• 8.4. Heat Map Analysis/ Company Market Position Analysis
• 8.5. Estimated Company Market Share Analysis, 2024
• 8.6. List of Other Key Market Players